Vimarsana
Biggest News Aggregation in the World

Elaine 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Elaine 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Elaine 2 Today - Breaking & Trending Today

ELAINE-3 Trial Sets Out to Confirm Clinical Benefit of Lasofoxifene/Abemaciclib in ESR1+-Mutant, ER+ Breast Cancer - Vimarsana News

ELAINE-3 Trial Sets Out to Confirm Clinical Benefit of Lasofoxifene/Abemaciclib in ESR1+-Mutant, ER+ Breast Cancer

Published: January 31, 2024

Seth A. Wander, MD, PhD, discusses key findings with lasofoxifene from ELAINE-1 and ELAINE-2 that supported the initiation of the ELAINE-3 trial.

Source: onclive.com
Related Topics:
United StatesHarvard Medical SchoolMassachusetts General HospitalEsr1 Er Her2 Metastatic Breast CancerElaine 3Elaine 1Elaine 2
Dr Jhaveri on the Rationale for the ELAINE-3 Trial in ESR1-Mutant ER+/HER2– Breast Cancer - Vimarsana News

Dr Jhaveri on the Rationale for the ELAINE-3 Trial in ESR1-Mutant ER+/HER2– Breast Cancer

Published: December 21, 2023

Komal Jhaveri, MD, FACP, discusses the rationale for investigating lasofoxifene alongside abemaciclib in ESR1-mutated estrogen receptor–positive, HER2-negative metastatic breast cancer.

Source: onclive.com
Related Topics:
James CayneKomal JhaveriMemorial Sloan Kettering Cancer CenterEarly Drug Development ServiceEndocrine Therapy Research ProgramJames Cayne ChairJunior FacultyElaine 3Elaine 1Elaine 2Esr1 MutantEr Her2 Negative Breast Cancer